6185.HK - CanSino Biologics Inc.

HKSE - HKSE Delayed Price. Currency in HKD
+0.450 (+1.26%)
At close: 3:54PM HKT
Stock chart is not supported by your current browser
Previous Close35.600
Bid36.050 x 0
Ask36.250 x 0
Day's Range36.000 - 36.600
52 Week Range29.300 - 45.750
Avg. Volume337,834
Market Cap8.027B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • How Much Of CanSino Biologics Inc. (HKG:6185) Do Insiders Own?
    Simply Wall St.20 days ago

    How Much Of CanSino Biologics Inc. (HKG:6185) Do Insiders Own?

    A look at the shareholders of CanSino Biologics Inc. (HKG:6185) can tell us which group is most powerful. Institutions...

  • Reuters3 months ago

    Biotech group Chi-Med plans Hong Kong listing of up to $500 mln - sources

    Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 million. Chi-Med, which is already listed on the London Stock Exchange and the Nasdaq in New York, filed its listing application with the Hong Kong stock exchange on Monday. "We are delighted to announce our proposed Hong Kong listing and global offering of shares," said Simon To, Chairman of Chi-Med, which is 60.2 percent owned by CK Hutchison.

  • We're sorry this is all we were able to find about this topic.